Conversion from cyclosporine to tacrolimus improves quality-of-life indices, renal graft function and cardiovascular risk profile

2004-06-01

Additional Metadata
Keywords	Cardiovascular risk, Cyclosporine, Nephrotoxicity, Renal transplantation, Side-effects, Tacrolimus
Persistent URL	doi.org/10.1111/j.1600-6143.2004.00427.x, hdl.handle.net/1765/66584
Journal	American Journal of Transplantation
Organisation	Department of Internal Medicine
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Artz, M.A, Boots, J.M.M, Ligtenberg, G, Roodnat, J.I, Christiaans, M.H, Vos, P.F, … Hilbrands, L.B. (2004). Conversion from cyclosporine to tacrolimus improves quality-of-life indices, renal graft function and cardiovascular risk profile. American Journal of Transplantation, 4(6), 937–945. doi:10.1111/j.1600-6143.2004.00427.x

Publication